Westwood Holdings Group’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,840
Closed -$466K 508
2023
Q1
$466K Buy
+11,840
New +$430K ﹤0.01% 402

Other funds holding IRMD

Westwood Holdings Group's IRMD Position: Q2 2023 in Review

Westwood Holdings Group sold out of iRadimed (IRMD) in Q2 2023, closing a stake of 11,840 shares — an estimated $466K sold.

Westwood Holdings Group first reported a position in IRMD in Q1 2023 and held it in 1 quarter. The position peaked at $466K in Q1 2023. 112 funds tracked by Wall St. Rank hold IRMD as of Q2 2023.

  • Westwood Holdings Group reported no remaining iRadimed position as of Q2 2023 after selling out during the quarter.
  • Westwood Holdings Group sold 11,840 iRadimed shares in Q2 2023, an estimated $466K.
  • Westwood Holdings Group first reported a position in iRadimed in Q1 2023 and held it in 1 quarter.
  • Westwood Holdings Group's iRadimed position peaked at $466K in Q1 2023.
  • 112 funds tracked by Wall St. Rank held iRadimed as of Q2 2023.

Based on Westwood Holdings Group's 13F filing for Q2 2023, filed 11 Aug 2023.